The proteasome: A key modulator of nervous system function, brain aging, and neurodegenerative disease

被引:37
作者
Davidson, Kanisa [1 ]
Pickering, Andrew M. [2 ]
机构
[1] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut CNET, Heersink Sch Med, Dept Neurol, Birmingham, AL 35294 USA
关键词
proteasome; immunoproteasome; synaptic plasticity; Alzheimer's disease; brain aging; ubiquitin proteasomal system; Parkinson's disease; huntington's disease; BETA-AMYLOID ACCUMULATION; LONG-TERM FACILITATION; 20S PROTEASOME; PROTEIN-DEGRADATION; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; LIFE-SPAN; IMMUNOPROTEASOME ACTIVITY; DEPENDENT DEGRADATION;
D O I
10.3389/fcell.2023.1124907
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The proteasome is a large multi-subunit protease responsible for the degradation and removal of oxidized, misfolded, and polyubiquitinated proteins. The proteasome plays critical roles in nervous system processes. This includes maintenance of cellular homeostasis in neurons. It also includes roles in long-term potentiation via modulation of CREB signaling. The proteasome also possesses roles in promoting dendritic spine growth driven by proteasome localization to the dendritic spines in an NMDA/CaMKIIa dependent manner. Proteasome inhibition experiments in varied organisms has been shown to impact memory, consolidation, recollection and extinction. The proteasome has been further shown to impact circadian rhythm through modulation of a range of 'clock' genes, and glial function. Proteasome function is impaired as a consequence both of aging and neurodegenerative diseases. Many studies have demonstrated an impairment in 26S proteasome function in the brain and other tissues as a consequence of age, driven by a disassembly of 26S proteasome in favor of 20S proteasome. Some studies also show proteasome augmentation to correct age-related deficits. In amyotrophic lateral sclerosis Alzheimer's, Parkinson's and Huntington's disease proteasome function is impaired through distinct mechanisms with impacts on disease susceptibility and progression. Age and neurodegenerative-related deficits in the function of the constitutive proteasome are often also accompanied by an increase in an alternative form of proteasome called the immunoproteasome. This article discusses the critical role of the proteasome in the nervous system. We then describe how proteasome dysfunction contributes to brain aging and neurodegenerative disease.
引用
收藏
页数:16
相关论文
共 147 条
[1]   Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease [J].
Alexopoulou, Zoi ;
Lang, Johannes ;
Perrett, Rebecca M. ;
Elschami, Myriam ;
Hurry, Madeleine E. D. ;
Kim, Hyoung Tae ;
Mazaraki, Dimitra ;
Szabo, Aron ;
Kessler, Benedikt M. ;
Goldberg, Alfred Lewis ;
Ansorge, Olaf ;
Fulga, Tudor A. ;
Tofaris, George K. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (32) :E4688-E4697
[2]   β-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system [J].
Almeida, CG ;
Takahashi, RH ;
Gouras, GK .
JOURNAL OF NEUROSCIENCE, 2006, 26 (16) :4277-4288
[3]   Differential inhibition of three peptidase activities of the proteasome in human lens epithelium by heat and oxidation [J].
Andersson, M ;
Sjöstrand, J ;
Karlsson, JO .
EXPERIMENTAL EYE RESEARCH, 1999, 69 (01) :129-138
[4]   Immune and non-immune functions of the immunoproteasome [J].
Angeles, Arkhjamil ;
Fung, Gabriel ;
Luo, Honglin .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2012, 17 :1904-1916
[5]  
Arduino DM, 2011, CURR PHARM DESIGN, V17, P3446
[6]   Protein degradation, as with protein synthesis, is required during not only long-term spatial memory consolidation but also reconsolidation [J].
Artinian, Julien ;
McGauran, Anne-Marie T. ;
De Jaeger, Xavier ;
Mouledous, Lionel ;
Frances, Bernard ;
Roullet, Pascal .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 27 (11) :3009-3019
[7]   Changes in 20S proteasome activity during ageing of the LOU rat [J].
Bardag-Gorce, F ;
Farout, L ;
Veyrat-Durebex, C ;
Briand, Y ;
Briand, M .
MOLECULAR BIOLOGY REPORTS, 1999, 26 (1-2) :89-93
[8]   Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies [J].
Bedford, Lynn ;
Hay, David ;
Devoy, Anny ;
Paine, Simon ;
Powe, Des G. ;
Seth, Rashmi ;
Gray, Trevor ;
Topham, Ian ;
Fone, Kevin ;
Rezvani, Nooshin ;
Mee, Maureen ;
Soane, Tim ;
Layfield, Robert ;
Sheppard, Paul W. ;
Ebendal, Ted ;
Usoskin, Dmitry ;
Lowe, James ;
Mayer, R. John .
JOURNAL OF NEUROSCIENCE, 2008, 28 (33) :8189-8198
[9]   Intersecting pathways to neurodegeneration in Parkinson's disease:: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin-proteasome system [J].
Betarbet, R ;
Canet-Aviles, RA ;
Sherer, TB ;
Mastroberardino, PG ;
McLendon, C ;
Kim, JH ;
Lund, S ;
Na, HM ;
Taylor, G ;
Bence, NF ;
Kopito, R ;
Seo, BB ;
Yagi, T ;
Klinefelter, G ;
Cookson, MR ;
Greenamyre, JT .
NEUROBIOLOGY OF DISEASE, 2006, 22 (02) :404-420
[10]   Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice:: exclusion of proteasome activator REGγ as a therapeutic target [J].
Bett, JS ;
Goellner, GM ;
Woodman, B ;
Pratt, G ;
Rechsteiner, M ;
Bates, GP .
HUMAN MOLECULAR GENETICS, 2006, 15 (01) :33-44